Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Jahn, C. Rio, O. Gigirey, L. Fueyo, C. Balaguer, A. Noguera, J. A. Torrecilla, M. A. Duran, S. Dosanjos, R. Llull, L. A. Ortiz, E. Sala-Llinas (Palma, Spain; Pittsburgh, United States Of America). Bone marrow-derived MSCs from patients with COPD have abnormal functional capacity. Eur Respir J 2013; 42: Suppl. 57, 250

Member's Comments

No comment yet.

Related content which might interest you: Impaired migration of bone marrow mesenchymal stem cells in COPD Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 LSC 2010 Abstract: Does cigarette smoking influence bone marrow microenvironment? Down-regulation of CXCR4 expression in bone marrow-derived mesenchymal stem cells (BM-MSCs) in patients with chronic obstructive pulmonary disease (COPD): preliminary results Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010 Functional comparison of bone-marrow derived mesenchymal stromal cells obtained from COPD patients and non-COPD controls Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015 Exogenous administration of bone marrow-derived stem cells in experimental COPD Source: Annual Congress 2013 –Cutting edge: drug delivery to the airways Year: 2013 Functional characterisation of bone marrow-derived mesenchymal stromal cells from COPD patients Source: ERJ Open Res 2016: 00045-2015 Year: 2016 Increased circulating fibrocytes and their capacity of proliferation and differentiation in clinically unstable patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Bone marrow progenitor cells in patients with COPD Source: Annual Congress 2010 - Novel insights into the pathophysiology of asthma and COPD Year: 2010 Endothelial progenitor cells are dysfunctional in smokers and COPD patients due to increased DNA damage and senescence Source: Annual Congress 2013 –Emerging new targets for the treatment of respiratory diseases Year: 2013 Intratracheal administration of bone marrow-derived mesenchymal stem cells ameliorates lung function Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models Year: 2016 Relationship of monocyte-derived macrophage phagocytosis to exacerbation susceptibility in stable COPD Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities Year: 2014 Myeloid derived suppressor cell-like fibrocytes are increased and associated with preserved lung function in COPD Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 IL-17A is elevated in patients with COPD and contributes to airway remodeling by acting on fibroblasts Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 Myofibroblast expression in airways and alveoli is affected by smoking and COPD Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Increased expression of TERT mRNA expresssion in bone marrow-derived mesenchymal stem cells (BM-MSCs) in patients with chronic obstructive pulmonary disease (COPD): Preliminary results Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010 Identification and characterization of mesenchymal stem cells in the human lung Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015 Neutrophil numbers are decreased in bronchial biopsies from patients with COPD Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 LATE-BREAKING ABSTRACT: Ultrastructural and functional properties of cultured lung cancer-associated myofibroblasts Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts Year: 2013 Expression of the biological axis VEGF-CXCL12/CXCR4 in bone marrow mesenchymal stem cells (BM MSCs) in patients with idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2008 - New insights into the pathogenesis of idiopathic pulmonary fibrosis and sarcoidosis Year: 2008 Preclinical studies of mesenchymal stem cell (MSC) transplantation in chronic obstructive pulmonary disease (COPD): A systematic review and meta-analysis Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 Enhanced neutrophil extracellular trap (NET) formation in sputum of stable COPD patients Source: International Congress 2015 – Mucosal immunology: what’s new in 2015 Year: 2015